Prescriber's Corner

Crizotinib: A Breakthrough for Targeted Therapies in Lung Cancer

Jennifer Kwon, PharmD, and ALISON MEAGHER, PharmD

From Roswell Park Cancer Institute, Buffalo, New York

The authors have no conflicts of interest to disclose.

Correspondence to: Jennifer Kwon, PharmD, Roswell Park Cancer Institute, Pharmacy Services, Elm and Carlton Streets, Buffalo, NY 14263. E-mail: jennifer.kwon@roswellpark.org


J Adv Pract Oncol 2012;3:267–272 | DOI: 10.6004/jadpro.2012.3.4.8 | © 2012 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here